Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 251 entries
View as:

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Phase: N/A Priority: Normal
NCT ID: NCT00041678 Org: User:
Start: 01/31/00 End: 03/31/03 Due: 03/31/04

A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices

Phase: N/A Priority: Normal
NCT ID: NCT00292409 Org: User:
Start: 03/31/05 End: 11/30/07 Due: 11/30/08

Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01145313 Org: User:
Start: 10/31/07 End: 06/30/10 Due: 06/30/11

A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.

Phase: N/A Priority: Normal
NCT ID: NCT03287869 Org: User:
Start: 10/24/17 End: 07/31/19 Due: 07/31/20

Aripiprazole in Patients With Acute Mania

Phase: N/A Priority: Normal
NCT ID: NCT00095511 Org: User:
Start: 06/30/04 End: 05/31/07 Due: 05/31/08

Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema

Phase: N/A Priority: Normal
NCT ID: NCT00874497 Org: User:
Start: 03/31/09 End: 08/31/15 Due: 08/31/16

Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT03850509 Org: User:
Start: 02/25/20 End: 05/22/20 Due: 05/22/21

A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type

Phase: N/A Priority: Normal
NCT ID: NCT03548584 Org: User:
Start: 05/16/18 End: 06/01/22 Due: 06/01/23

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment

Phase: N/A Priority: Normal
NCT ID: NCT02013609 Org: User:
Start: 11/30/13 End: 10/31/14 Due: 10/31/15

Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT05536414 Org: User:
Start: 09/12/22 End: 05/16/25 Due: 05/16/26

Oral Aripiprazole Open-Label Rollover Study

Phase: N/A Priority: Normal
NCT ID: NCT01001702 Org: User:
Start: 04/30/06 End: 07/31/12 Due: 07/31/13

A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683

Phase: N/A Priority: Normal
NCT ID: NCT02573350 Org: User:
Start: 03/26/09 End: 10/27/11 Due: 10/27/12

Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00095810 Org: User:
Start: 07/31/03 End: 09/30/04 Due: 09/30/05

Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN)

Phase: N/A Priority: Normal
NCT ID: NCT05248646 Org: User:
Start: 03/15/22 End: 12/30/26 Due: 12/30/27

A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04786730 Org: User:
Start: 03/09/21 End: 04/26/23 Due: 04/26/24

Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01909466 Org: User:
Start: 07/31/13 End: 04/30/14 Due: 04/30/15

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Phase: N/A Priority: Normal
NCT ID: NCT01360645 Org: User:
Start: 07/31/11 End: 06/30/13 Due: 06/30/14

Study of Rebamipide Eye Drops to Treat Dry Eye

Phase: N/A Priority: Normal
NCT ID: NCT00201981 Org: User:
Start: 05/31/04 End: 02/28/07 Due: 02/28/08

Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia

Phase: N/A Priority: Normal
NCT ID: NCT00095719 Org: User:
Start: 12/31/03 End: 03/31/05 Due: 03/31/06

A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia.

Phase: N/A Priority: Normal
NCT ID: NCT04865835 Org: User:
Start: 05/12/21 End: 05/03/22 Due: 05/03/23

CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission

Phase: N/A Priority: Normal
NCT ID: NCT00092508 Org: User:
Start: 05/31/04 End: 05/31/07 Due: 05/31/08

Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02054702 Org: User:
Start: 02/28/14 End: 07/31/14 Due: 07/31/15

Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders

Phase: N/A Priority: Normal
NCT ID: NCT03292848 Org: User:
Start: 10/10/17 End: 05/21/18 Due: 05/21/19

Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT00239356 Org: User:
Start: 03/31/03 End: 10/31/12 Due: 10/31/13

A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT02068352 Org: User:
Start: 06/20/14 End: 02/03/15 Due: 02/03/16